Is Tectonic Therapeutic, Stock a Good Investment?
Tectonic Therapeutic, Investment Advice | TECX |
- Examine Tectonic Therapeutic,'s financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Tectonic Therapeutic,'s leadership team and their track record. Good management can help Tectonic Therapeutic, navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Tectonic Therapeutic,'s business and its evolving consumer preferences.
- Compare Tectonic Therapeutic,'s performance and market position to its competitors. Analyze how Tectonic Therapeutic, is positioned in terms of product offerings, innovation, and market share.
- Check if Tectonic Therapeutic, pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Tectonic Therapeutic,'s stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Tectonic Therapeutic, stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Tectonic Therapeutic, is a good investment.
Sell | Buy |
Strong Buy
Market Performance | Solid | Details | |
Volatility | Very steady | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Tectonic Therapeutic, Stock
Researching Tectonic Therapeutic,'s stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 39.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.59. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tectonic Therapeutic, recorded a loss per share of 3.07. The entity had not issued any dividends in recent years. The firm had 1:12 split on the 21st of June 2024.
To determine if Tectonic Therapeutic, is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Tectonic Therapeutic,'s research are outlined below:
| Tectonic Therapeutic, appears to be risky and price may revert if volatility continues | |
| Tectonic Therapeutic, was previously known as AVROBIO and was traded on NASDAQ Exchange under the symbol AVRO. | |
| Net Loss for the year was (42.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Tectonic Therapeutic, generates negative cash flow from operations | |
| Tectonic Therapeutic, has a frail financial position based on the latest SEC disclosures | |
| About 39.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Tectonic Therapeutic To Present on December 3rd, 2024at the Piper Sandler Healthcare Conference |
Tectonic Therapeutic, Quarterly Liabilities And Stockholders Equity |
|
Earnings surprises can significantly impact Tectonic Therapeutic,'s stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Tectonic Therapeutic,'s investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-07 | 2024-09-30 | -0.82 | -1.2029 | -0.3829 | 46 | ||
2024-03-20 | 2023-12-31 | -4.04 | -2.4 | 1.64 | 40 | ||
2023-11-09 | 2023-09-30 | -3.4 | -5.28 | -1.88 | 55 | ||
2024-05-09 | 2024-03-31 | -4.32 | -1.8 | 2.52 | 58 | ||
2024-08-08 | 2024-06-30 | -1.5 | -4.3396 | -2.8396 | 189 |
Tectonic Therapeutic,'s market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 265.07 M.Market Cap |
|
Tectonic Therapeutic,'s profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.42) | (0.44) | |
| Return On Capital Employed | (0.47) | (0.49) | |
| Return On Assets | (0.42) | (0.44) | |
| Return On Equity | (0.45) | (0.47) |
Determining Tectonic Therapeutic,'s profitability involves analyzing its financial statements and using various financial metrics to determine if Tectonic Therapeutic, is a good buy. For example, gross profit margin measures Tectonic Therapeutic,'s profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Tectonic Therapeutic,'s profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Tectonic Therapeutic,'s accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tectonic Therapeutic,. Check Tectonic Therapeutic,'s Beneish M Score to see the likelihood of Tectonic Therapeutic,'s management manipulating its earnings.
Basic technical analysis of Tectonic Stock
As of the 29th of November, Tectonic Therapeutic, has the Semi Deviation of 2.41, coefficient of variation of 306.11, and Risk Adjusted Performance of 0.2587. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tectonic Therapeutic,, as well as the relationship between them.Tectonic Therapeutic,'s insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tectonic Therapeutic, insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tectonic Therapeutic,'s material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tectonic Therapeutic, insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ruddy Marcella K. few days ago Acquisition by Ruddy Marcella K. of 18704 shares of Tectonic Therapeutic, at 5.38 subject to Rule 16b-3 | ||
Springer Timothy A over two months ago Acquisition by Springer Timothy A of 186134 shares of Tectonic Therapeutic, subject to Rule 16b-3 | ||
Reicin Alise over two months ago Acquisition by Reicin Alise of 33923 shares of Tectonic Therapeutic, at 2.38 subject to Rule 16b-3 | ||
Ruddy Marcella K. over three months ago Acquisition by Ruddy Marcella K. of 18704 shares of TECX at 5.38 subject to Rule 16b-3 |
Understand Tectonic Therapeutic,'s technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Tectonic Therapeutic,'s various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.2587 | |||
| Market Risk Adjusted Performance | 1.67 | |||
| Mean Deviation | 3.4 | |||
| Semi Deviation | 2.41 | |||
| Downside Deviation | 3.44 | |||
| Coefficient Of Variation | 306.11 | |||
| Standard Deviation | 4.81 | |||
| Variance | 23.13 | |||
| Information Ratio | 0.3006 | |||
| Jensen Alpha | 1.45 | |||
| Total Risk Alpha | 0.837 | |||
| Sortino Ratio | 0.4206 | |||
| Treynor Ratio | 1.66 | |||
| Maximum Drawdown | 28.88 | |||
| Value At Risk | (4.96) | |||
| Potential Upside | 7.76 | |||
| Downside Variance | 11.82 | |||
| Semi Variance | 5.8 | |||
| Expected Short fall | (4.31) | |||
| Skewness | 1.35 | |||
| Kurtosis | 4.22 |
| Risk Adjusted Performance | 0.2587 | |||
| Market Risk Adjusted Performance | 1.67 | |||
| Mean Deviation | 3.4 | |||
| Semi Deviation | 2.41 | |||
| Downside Deviation | 3.44 | |||
| Coefficient Of Variation | 306.11 | |||
| Standard Deviation | 4.81 | |||
| Variance | 23.13 | |||
| Information Ratio | 0.3006 | |||
| Jensen Alpha | 1.45 | |||
| Total Risk Alpha | 0.837 | |||
| Sortino Ratio | 0.4206 | |||
| Treynor Ratio | 1.66 | |||
| Maximum Drawdown | 28.88 | |||
| Value At Risk | (4.96) | |||
| Potential Upside | 7.76 | |||
| Downside Variance | 11.82 | |||
| Semi Variance | 5.8 | |||
| Expected Short fall | (4.31) | |||
| Skewness | 1.35 | |||
| Kurtosis | 4.22 |
Consider Tectonic Therapeutic,'s intraday indicators
Tectonic Therapeutic, intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tectonic Therapeutic, stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Tectonic Therapeutic, time-series forecasting models is one of many Tectonic Therapeutic,'s stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tectonic Therapeutic,'s historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Tectonic Stock media impact
Far too much social signal, news, headlines, and media speculation about Tectonic Therapeutic, that are available to investors today. That information is available publicly through Tectonic media outlets and privately through word of mouth or via Tectonic internal channels. However, regardless of the origin, that massive amount of Tectonic data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Tectonic Therapeutic, news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Tectonic Therapeutic, relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Tectonic Therapeutic,'s headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Tectonic Therapeutic, alpha.
Tectonic Therapeutic, Corporate Management
| Daniel MBA | Chief Officer | Profile | |
| MS MD | Chief Officer | Profile | |
| Christian Cortis | Executive Officer | Profile | |
| Peter McNamara | Chief Officer | Profile | |
| Anthony MD | Chief Officer | Profile | |
| John Diener | Senior Sciences | Profile | |
| Marc Schwabish | Chief Officer | Profile |
Additional Tools for Tectonic Stock Analysis
When running Tectonic Therapeutic,'s price analysis, check to measure Tectonic Therapeutic,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tectonic Therapeutic, is operating at the current time. Most of Tectonic Therapeutic,'s value examination focuses on studying past and present price action to predict the probability of Tectonic Therapeutic,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tectonic Therapeutic,'s price. Additionally, you may evaluate how the addition of Tectonic Therapeutic, to your portfolios can decrease your overall portfolio volatility.